www.newsy-today.com
Jakarta, CNBC Indonesia – The results of the final trial of the CureVac vaccine from Germany are apparently unsatisfactory. The vaccine only has a 48% efficacy rate against the corona …
Sunday June 20th 2021 Vaccine debacle Curevac – a terribly normal setback A comment by Horst von Buttlar Digesting the Curevac fright will take time. But the first conclusions have …
Representatives of health organizations in several countries have expressed concern about the prevalence of the delta variant (also called the Indian variant). The United Kingdom reports a rapid increase in …
It is these hours the news of the flop of vaccine German CureVac produced in Tübingen. In Italy 30 million doses of this messenger mRNA vaccine were expected Pfizer e …
The German biotech CureVac collapsed this morning in the markets after hours after reporting the low efficacy of its vaccine against Covid-19. The firm, which uses the same messenger RNA …
German CureVac has only 47% protection against mRNA vaccine myth Central News Agency News Lu’s first domestic mRNA vaccine launches Phase III clinical trial Chinatimes.com Chinatimes.com No need to freeze …
Inflation in Colombia in May was the highest since 2017, reaching 1%. This was revealed by Juan Daniel Oviedo, director of Dane. This month the increase in consumer prices was …
The German serum will become the fifth formula authorized by the EMA in mid-June, about to conclude the study in which 1,500 Basques participate successfully Image of the trial with …
The drug requires two doses and has “better” storage conditions than Pfizer or Moderna The German CureVac vaccine may represent a turning point in the vaccination plan in Spain. The …
A NEWS editor from GIPUZKOA participates as a volunteer in the clinical trial of the Curevac antidote that is being carried out at Biodonostia. Among so many vaccines, whether they …
/nginx/o/2021/06/19/13860107t1h0b15.jpg)
